Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Journal De Pharmacie De Belgique|February 27, 2010
[Orphan diseases and orphan medicines: a Belgian and European study]Alain Denis, Lut Mergaert, Christel Fostier, et al.
International Journal of Technology Assessment in Health Care|February 7, 2014
Harmonization of ethics in health technology assessment: a revision of the Socratic approachBjørn Hofmann, Sigrid Droste, Wija Oortwijn, et al.
Journal of Health Economics|November 4, 2020
It runs in the family - Influenza vaccination and spillover effectsNicolas Bouckaert, Anne C Gielen, Tom Van Ourti
Transplantation|July 17, 2003
Health professionals' perceptions of health status after renal transplantation: a comparison with transplantation candidates' expectationsIrina Cleemput, Katrien Kesteloot, Sabina De Geest, et al.
International Journal of Technology Assessment in Health Care|January 26, 2011
Using threshold values for cost per quality-adjusted life-year gained in healthcare decisionsIrina Cleemput, Mattias Neyt, Nancy Thiry, et al.
Health Policy (Amsterdam, Netherlands)|May 14, 2013
Development of a national position paper for chronic care: example of BelgiumDominique Paulus, Koen Van den Heede, Sophie Gerkens, et al.
Health Policy (Amsterdam, Netherlands)|January 13, 2009
Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literatureMattias Neyt, Hans Van Brabandt, Stephan Devriese, et al.
Acta Gastro-Enterologica Belgica|August 25, 2007
A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levelsSophie Gerkens, Myriam Nechelput, Lieven Annemans, et al.
International Archives of Allergy and Immunology|June 30, 2021
Unraveling the Mystery of Polyvalent Immunoglobulins in Belgium: Do We Have an Indication?Christophe de Meester, Jolyce Bourgeois, Stephan Devriese, et al.
BMC Pulmonary Medicine|September 17, 2010
Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditionsMattias Neyt, Stephan Devriese, Nancy Thiry, et al.
Pageof 12